XML 48 R30.htm IDEA: XBRL DOCUMENT v3.22.1
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative) - USD ($)
 12 Months Ended
Feb. 13, 2020
Oct. 01, 2019
Dec. 31, 2021
Dec. 31, 2020
Oct. 02, 2019
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]          
Registration Payment Arrangement, Event to Transfer Consideration   On October 1, 2019, the Company entered into an agreement with a consultant for toxicology studies. The consultant quoted a commitment of approximately $      
[custom:ProtocolPricePlusFee]   $ 7,000      
Payments for consultant     $ 7,697 $ 594,134  
Due to consultant     $ 0    
Number of option shares issued     583,000    
Options exercise price     $ 1.48    
Consultant [Member]          
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]          
Estimate commitment amount         $ 988,000
CFO [Member]          
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]          
Number of option shares issued 187,497        
Number of option shares issued, value $ 93,950        
Options exercise price $ 1.75        
Option expired term 10 years